Search results
Harpoon Therapeutics, Inc. (HARP) Beats Q2 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 9 months agoHarpoon Therapeutics, Inc. (HARP) delivered earnings and revenue surprises of 106.98% and 120.03%,...
Harpoon Therapeutics, Inc. (HARP) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 5 months agoHarpoon Therapeutics, Inc. (HARP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting...
While private equity firms own 20% of Harpoon Therapeutics, Inc. (NASDAQ:HARP), retail investors are...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Significant control over Harpoon Therapeutics by retail investors implies that the...
Analysts Just Shipped A Meaningful Upgrade To Their Harpoon Therapeutics, Inc. (NASDAQ:HARP)...
Simply Wall St. via Yahoo Finance· 11 months agoShareholders in Harpoon Therapeutics, Inc. (NASDAQ:HARP) may be thrilled to learn that the analysts...
Growth Investors: Industry Analysts Just Upgraded Their Harpoon Therapeutics, Inc. (NASDAQ:HARP)...
Simply Wall St. via Yahoo Finance· 2 years agoHarpoon Therapeutics, Inc. (NASDAQ:HARP) shareholders will have a reason to smile today, with the...
Shareholders in Harpoon Therapeutics (NASDAQ:HARP) are in the red if they invested three years ago
Simply Wall St. via Yahoo Finance· 2 years agoHarpoon Therapeutics, Inc. (NASDAQ:HARP) shareholders should be happy to see the share price up 16%...
Analysts Just Made A Major Revision To Their Harpoon Therapeutics, Inc. (NASDAQ:HARP) Revenue...
Simply Wall St. via Yahoo Finance· 2 years agoToday is shaping up negative for Harpoon Therapeutics, Inc. (NASDAQ:HARP) shareholders, with the...
Should You Buy Harpoon Therapeutics, Inc. (HARP) After Golden Cross?
Zacks via Yahoo Finance· 5 months agoHarpoon Therapeutics, Inc. (HARP) reached a significant support level, and could be a good pick for...
Wall Street Analysts Believe Harpoon Therapeutics, Inc. (HARP) Could Rally 40.5%: Here's is How to...
Zacks via Yahoo Finance· 5 months agoThe consensus price target hints at a 40.5% upside potential for Harpoon Therapeutics, Inc. (HARP)....
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
Zacks via Yahoo Finance· 5 months agoHarpoon Therapeutics HARP develops a novel class of T cell engagers, leveraging its proprietary...